Aggressive "triple-negative" breast cancers may be sensitive to drugs that clog their

[News]

In a new paper in Cancer Cell, a team led by Judy Lieberman, PhD, of Boston Children's Hospital's Program in Cellular and Molecular Medicine reports "triple-negative" breast cancers may be vulnerable to drugs that attack the proteasome. This cellular structure acts as the cell's waste disposal, breaking down damaged or unneeded proteins...

More... (http://www.medicalnewstoday.com/releases/264750.php)